Background/Aims: The aim of this study was to evaluate the characteristics of pruritus in pediatric patients undergoing peritoneal dialysis. Patients and Methods: Twenty-seven patients (16 females, 11 males), aged between 5 and 18 years, were evaluated for the presence, intensity, onset, activation time, duration, characteristics, localization and increasing factors for pruritus. The intensity of pruritus was scored using a visual analog scale. Patients were grouped according to the existence of pruritus and other clinical and laboratory parameters (dialysis duration, dialysis adequacy, hemoglobin, blood urea nitrogen, creatinine, Ca, P, albumin, bicarbonate, parathyroid hormone (PTH), C-reactive protein (CRP)) were compared between the 2 groups. Results: The mean age of patients was 11.85 ± 4.4 years. There were 21 patients (77.7%) without pruritus and 6 patients with pruritus (22.2%). Serum P, PTH, CRP levels and Ca×P product were significantly higher in patients with pruritus compared to patients without pruritus (p = 0.027, p = 0.03, p < 0.026, p = 0.031, respectively). In a stepwise logistic regression model, P (p = 0.01), Ca×P product (p = 0.09), PTH (p = 0.03) and CRP (p = 0.02) were independently associated with pruritus. Conclusion: Our study indicates that pruritus remains a common but not troublesome symptom in children on peritoneal dialysis. Higher serum P, Ca×P product, PTH and CRP concentrations appear to be important factors associated with uremic pruritus in this group.

1.
Mistik S, Utas S, Ferahbas A, et al: An epidemiologic study of patients with uremic pruritus. J Eur Acad Dermatol Venereol 2006;20:672–678.
2.
Dyachenko P, Shustak A, Rozenman D: Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol 2006;45:664–667.
3.
Dar NR, Akhter A: Clinical characteristics of uremic pruritus in patients undergoing haemodialysis. J Coll Physicians Surg Pak 2006;16:94–96.
4.
Pisoni RL, Wikstrom B, Elder SJ, et al: Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006;21:3495–3505.
5.
Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G: Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol 2006;66:184–191.
6.
Carmichael AJ, McHugh MI, Martin AM: Renal itch as an indicator of poor outcome. Lancet 1991;337:1225–1226.
7.
Urbonas A, Schwartz RA, Szepietowski JC: Uremic pruritus-an update. Am J Nephrol 2001;21:343–350.
8.
Zucker I, Yosipovitch G, David M, Gafter U, Boner G: Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol 2003;49:842–846.
9.
Yosipovitch G, Duque MI, Patel TS, Ishiuji Y, Guzman-Sanchez DA, et al: Skin barrier structure and function and their relationship to pruritus in end-stage renal disease. Nephrol Dial Transplant 2007;22:3268–3272.
10.
Mettang T, Pauli-Magnus C, Alscher DM: Uraemic pruritus – new perspectives and insights from recent trials. Nephrol Dial Transplant 2002;17:1558–1563.
11.
Schwab M, Mikus G, Mettang T, Pauli-Magnus C, Kuhlmann U; Arbeitsgemeinschaft für Pädiatrische Nephrologie: Urämischer Pruritus im Kindes- und Jugendalter. Monatsschr Kinderheilkd 1999;147:232.
12.
Szepietowski J, Thepen T, van Vloten WA, Szepietowski T, Bihari IC: Pruritus and mast cell proliferation in the skin of haemodialysis patients. Inflamm Res 1995;44(suppl 1):S84–S85.
13.
Rosen T: Uremic pruritus: a review. Cutis 1979;23:790–792.
14.
Cho YL, Liu HN, Huang TP, Tarng DC: Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 1997;36:538–543.
15.
Graf H, Kovarik J, Stummvoll HK, Wolf A: Disappearance of uraemic pruritus after lowering dialysate magnesium concentration. Br Med J 1979;2:1478–1479.
16.
Blachley JD, Blankenship DM, Menter A, Parker TF 3rd, Knochel JP: Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis 1985;5:237–241.
17.
Hampers CL, Katz AL, Wilson RE, et al: Disappearance of ‘uremic’ itching after subtotal parathyroidectomy. N Engl J Med 1968;279:695–697.
18.
Stahle-Backdahl M, Hagermark O, Lins L-E, et al: Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus. J Intern Med 1989;225:411–415.
19.
Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, et al: The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006;21:749–755.
20.
Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990;37:116–125.
21.
Virga G, Visentin I, La Milia V, Bonadonna A: Inflammation and pruritus in hemodialysis patients. Nephrol Dial Transplant 2002;17:2164–2169.
22.
Akhyani M, Ganji MR, Samadi N, Khamesan B, Daneshpazhooh M: Pruritus in hemodialysis patients. BMC Dermatol 2005;24:7.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.